SCHEMBL20735153

SCHEMBL20735153

O=C1c2cccc3c(-c4ccc5c(c4)oc4ccccc45)ccc(c23)C(=O)N1c1ccc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ KMT2A Q03164 6/20 0.40
▸ USP2 O75604 5/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ KEAP1 Q14145 4/20 0.40
▸ NFE2L2 Q16236 4/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ TP53 P04637 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735154 0.94 ALDH1A1 (0.48) PTGER4ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL20735099 0.88 KMT2A (0.53) PTGER4ALDH1A1LMNAKMT2AUSP2
SCHEMBL20735222 0.87 ALDH1A1 (0.58) ALDH1A1LMNACYP1A2CYP2C9HPGD
SCHEMBL20735117 0.86 ALDH1A1 (0.52) PTGER4ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL20735230 0.84 ALDH1A1 (0.50) PTGER4ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL20735161 0.83 ALDH1A1 (0.53) ALDH1A1LMNACYP1A2CYP2C9HPGD
SCHEMBL20735216 0.82 ALDH1A1 (0.58) ALDH1A1LMNACYP1A2CYP2C9HPGD
SCHEMBL20735237 0.81 ALDH1A1 (0.56) ALDH1A1LMNACYP1A2CYP2C9HPGD
SCHEMBL20735172 0.80 MEN1 (0.49) PTGER4ALDH1A1CYP1A2HPGDKMT2A
SCHEMBL20735232 0.80 ALDH1A1 (0.58) ALDH1A1LMNACYP1A2CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
EP-3442047-B1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO LTD (KR) 2021-05-05 — — EP disclosed
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190051856-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS ALDH1A1, AOX1, ALDH1A2 PTGER4 2918/4885ALDH1A1 1/4885LMNA 2716/4885
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit ALDH1A1, AOX1, AMY1A PTGER4 2993/4885ALDH1A1 1/4885LMNA 2468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback